speb/financial-data huggingface dataset:
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 58256000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 827000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 4153000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 153000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 153000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Work In Process: 119005000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Working Capital: 339123000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — +Operating Expense: 390003000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — +Total Revenue: 1210628000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 192819000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 362908000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -355231000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1292000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Amortization: 13266000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 13266000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 11860000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 170678409.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.72
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 179000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 227229000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -27310000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 97832000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 163141000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 419000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 419000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 419000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -169977000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Change In Payable: 26212000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -57658000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -201423000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 240000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Common Stock: 163141000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 691616000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1484000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 618514000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Current Assets: 1030553000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 10061000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Current Debt: 344122000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 354183000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 552995000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Depreciation: 47641000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 60907000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 60907000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 47641000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 170678409.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Diluted EPS: 0.72
IRISDOREME.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 122119000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — EBIT: 202340000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — EBITDA: 263247000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — End Cash Position: 419000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 10276000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 219035000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -10187000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 10270000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 218000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 632773000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Gross Profit: 592114000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Interest Expense: 37402000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 37402000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Interest Income: 970000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 970000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -30378000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 969000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Inventory: 619181000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 1035738000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -27159000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 11860000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 59294000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1835000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 87771000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 87771000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 374391000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Net Debt: 343703000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income: 122119000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 122119000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 122119000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 122119000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 122119000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 164938000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 122119000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Interest Income: -37460000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -818000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 59294000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -37460000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Net PPE: 277542000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -27310000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 59294000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 691398000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 12210000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 11860000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 263247000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Normalized Income: 122119000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 17123000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Operating Income: 202111000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Operating Revenue: 1210628000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 170678409.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 1456000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 528476000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 218000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 37461000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -2000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 1000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 970000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 82180000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Payable: -39000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Properties: 27834000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 471000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 15361000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Payables: 197260000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 0.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 28828000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Pretax Income: 164938000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -27310000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 64330000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 618514000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 60907000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 4661000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 4661000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 15361000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 527183000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 25135000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 35405000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Share Issued: 170678409.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 59294000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 691616000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 691398000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Tax Provision: 42819000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.28
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 3385000.00
IRISDOREME.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -44759000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Assets: 1332383000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 691616000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Debt: 441954000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 691616000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Total Expenses: 1008517000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 640767000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 301828000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 87772000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 1028000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 4480000.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 0.00
IRISDOREME.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Work In Process: 335816000.00
IRISDOREME.NS balance_sheet (annual, 2024-03-31) — Working Capital: 477558000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 232156000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 463438000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 136658000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 163141000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 475000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 8671000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 163141000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 754278000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1138141000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 15819000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 331199000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 347018000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 585006000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 126000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 293733000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 639093000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 1085477000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 120839000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 120839000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 330724000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 293733000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 754152000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 14731000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 170678410.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 28944000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 5871000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 591137000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 126000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 1000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 293733000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 521000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 8196000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Payables: 232156000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 170678410.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 754278000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 754152000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: -2526000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 1460124000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 754278000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 467857000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 754278000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 705846000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 321982000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 120840000.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
IRISDOREME.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 553135000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 124030000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 333757000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 158266667.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.15
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 167251000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 17925000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 17925000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 158266667.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.15
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — EBIT: 42686000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — EBITDA: 60611000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 166506000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 10908000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 10908000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Income: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -10908000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -10908000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 60611000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 23740000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Operating Income: 42476000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 333757000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 210000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 39350000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 31778000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 167251000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 17925000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 8038000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 291281000.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
IRISDOREME.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — +Operating Expense: 479324000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 122734000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — +Total Revenue: 1462733000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 402036000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 234411000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 234411000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 529705000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 529705000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -418125000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -418125000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1292000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1292000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Amortization: 19230000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 19230000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 164028750.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 186754167.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Basic EPS: 0.80
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.24
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 419000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 272851000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 272851000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -8448000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 129140000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 129140000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 163141000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 163141000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 760000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 760000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 760000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 760000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 760000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 760000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -77875000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Change In Payable: 41703000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -174873000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -211045000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 341000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Common Stock: 163141000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 163141000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 822839000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 822839000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 766303000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 208389000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1270318000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1270318000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 15819000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 15819000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Current Debt: 375160000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 375160000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 390979000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 390979000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 631494000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 631494000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Depreciation: 62980000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 62980000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 62980000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 10130000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 62980000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 10130000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 164028750.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 186754167.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Diluted EPS: 0.80
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.24
IRISDOREME.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 44821000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — EBIT: 220166000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — EBIT: 72142000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — EBITDA: 283146000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — EBITDA: 82272000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — End Cash Position: 760000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -25372000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 274491000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 274491000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 16900000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 10590000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1068000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1068000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 685994000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 685994000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Gross Profit: 696430000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 193647000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Interest Expense: 42011000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 10906000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 42011000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 10906000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Interest Income: 1895000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 1895000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -30294000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 1895000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Inventory: 697056000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 697056000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1197999000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1197999000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 365000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 31038000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1835000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1835000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 113321000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 113321000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 113321000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 113321000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 382941000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 382941000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Net Debt: 374400000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 374400000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Income: 44821000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 44821000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 44821000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 0.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 44821000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 44821000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 178155000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 44821000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Interest Income: -42011000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -10906000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 6918000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 31038000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -42011000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -10906000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Net PPE: 267869000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 267869000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -8448000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 31038000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 821771000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 821771000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 14854000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 14854000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 13549000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 13549000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 283146000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 82272000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Normalized Income: 131223000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 44821000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 25348000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Operating Income: 217106000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Operating Income: 70913000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Operating Revenue: 1462733000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 402036000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 170678410.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 170678410.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 34608000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 34608000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1121000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1121000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 659699000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 659699000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1068000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1068000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 40116000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -2000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -2000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 2000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 3060000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1229000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 172297000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 52823000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Payable: 789000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 789000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Properties: 28367000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 28367000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1079000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1079000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 8443000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8443000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Other Special Charges: -68000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Payables: 238907000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Payables: 238907000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 0.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 34608000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 34608000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Pretax Income: 178155000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 61236000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -8448000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 71100000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 71100000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 766303000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 208389000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 62980000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 10130000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 5958000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 5958000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 8443000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 8443000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 658406000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 658406000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 19262000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 29852000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Share Issued: 170678410.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 170678410.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 31038000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 822839000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 822839000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 821771000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 821771000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Tax Provision: 46932000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 16415000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: -1333000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: -1333000.00
IRISDOREME.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -44858000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1567656000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1567656000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 822839000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 822839000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Debt: 504300000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 504300000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 822839000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 822839000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Total Expenses: 1245627000.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 331123000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 744817000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 744817000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 297338000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 297338000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 113323000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 113323000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 735000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 3707000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 3707000.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
IRISDOREME.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Work In Process: 351465000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 351465000.00
IRISDOREME.NS balance_sheet (annual, 2025-03-31) — Working Capital: 638824000.00
IRISDOREME.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 638824000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 118025000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 373990000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 170678410.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 214118000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 10821000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 10821000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 170678410.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — EBIT: 42116000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — EBITDA: 52937000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 159872000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 5789000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 5789000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Income: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -5789000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -5789000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 52937000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 26301000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Operating Income: 41847000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 373990000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 269000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 55368000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 36327000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 214118000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 10821000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 10026000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 332143000.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 133263000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 486680000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 188200000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.16
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 305188000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 12012000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 12012000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 188200000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.16
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — EBIT: 48578000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — EBITDA: 60590000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 181492000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 7031000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 7031000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Income: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 30112000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -7031000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -7031000.00
IRISDOREME.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 60590000.00